Clinical Trial Update: Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment Evaluation: STARGATE [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating sorafenib in advanced and/or recurrent gastric adenocarcinoma (STARGATE) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastric Cancer

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: Asan Medical Center | Conditions: Malignant Neoplasm of Stomach, Effects of Chemotherapy | Phase 2 | Status: COMPLETED